Carson Wealth (CWM LLC)’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $589K | Buy |
27,322
+21,477
| +367% | +$463K | ﹤0.01% | 1515 |
|
|
2025
Q1 | $97K | Buy |
5,845
+1,951
| +50% | +$32.4K | ﹤0.01% | 2442 |
|
|
2024
Q4 | $71K | Buy |
3,894
+1,646
| +73% | +$30K | ﹤0.01% | 2513 |
|
|
2024
Q3 | $35K | Buy |
2,248
+136
| +6% | +$2.12K | ﹤0.01% | 2958 |
|
|
2024
Q2 | $34K | Buy |
2,112
+96
| +5% | +$1.55K | ﹤0.01% | 2736 |
|
|
2024
Q1 | $37K | Buy |
2,016
+24
| +1% | +$440 | ﹤0.01% | 2489 |
|
|
2023
Q4 | $62K | Sell |
1,992
-71
| -3% | -$2.21K | ﹤0.01% | 2034 |
|
|
2023
Q3 | $43K | Sell |
2,063
-144
| -7% | -$3K | ﹤0.01% | 2152 |
|
|
2023
Q2 | $53K | Sell |
2,207
-158
| -7% | -$3.79K | ﹤0.01% | 1929 |
|
|
2023
Q1 | $45K | Buy |
2,365
+2,335
| +7,783% | +$44.4K | ﹤0.01% | 1927 |
|
|
2022
Q4 | $0 | Sell |
30
-62
| -67% | – | ﹤0.01% | 3922 |
|
|
2022
Q3 | $2K | Sell |
92
-6
| -6% | -$130 | ﹤0.01% | 3395 |
|
|
2022
Q2 | $1K | Buy |
98
+23
| +31% | +$235 | ﹤0.01% | 3457 |
|
|
2022
Q1 | $2K | Buy |
75
+43
| +134% | +$1.15K | ﹤0.01% | 3106 |
|
|
2021
Q4 | $1K | Buy |
+32
| New | +$1K | ﹤0.01% | 3218 |
|